Login Logout or Register

  • Epilepsy Home
  • Population Management
    Overview
    • Quality Measures
    • Innovation Showcase
    • Adherence & Readmissions
    • Long-Term Care
  • Epilepsy Overview
    Overview
    • Burden of Illness
    • ICD-9 CM to ICD-10 CM Code Conversion
    • Video Library
  • Product Information
    Overview
    • APTIOM Prescribing Information
    • APTIOM Overview
    • Structure & Pharmacology
    • Efficacy
    • Adult Adverse Reactions
    • Pediatric Adverse Reactions
    • Adult Dosing
    • Pediatric Dosing
    • Formulary Access & Support
    • Sunovion Answers

Select a Disease State:

  • Epilepsy Adult / Pediatric
  • Bipolar Depression in Adult Patients
  • Bipolar Depression in Pediatric Patients
  • Schizophrenia in Adults
  • Schizophrenia in Adolescents
  • Chronic Obstructive Pulmonary Disease (COPD)

Population Management

Find interactive tools focused on Quality Measures, epilepsy-specific population data, and a showcase of innovative management solutions.

Explore Insights, Resources, and Tools for Epilepsy

  • QUALITY MEASURES

    Review Healthcare Effectiveness Data Information Set, Medicare Star Ratings, and other quality measures for epilepsy

    Go Now

  • ADHERENCE & READMISSIONS

    See how adherence and readmissions are being managed with interventions, programs, and strategies that are currently working

    Go Now

  • INNOVATION SHOWCASE

    New population management techniques to better manage neurological health patient populations

    Go Now

  • LONG-TERM CARE

    Review important considerations for older adults with epilepsy in long-term care facilities

    Go Now

Learn more about adherence and readmissions for epilepsy

Sunovion Sunovion

SUNOVION and   are registered trademarks of Sumitomo Dainippon Pharma Co., Ltd. Sunovion Pharmaceuticals Inc. is a U.S. subsidiary of Sumitomo Dainippon Pharma Co., Ltd.

XOPENEX HFA and BROVANA are registered trademarks of Sunovion Pharmaceuticals Inc.

APTIOM is a registered trademark of , used under license.  LATUDA is a registered trademark of Sumitomo Dainippon Pharma Co., Ltd.

ARCAPTA, ,  UTIBRON, , SEEBRI, , and NEOHALER are registered trademarks of Novartis AG, used under license. 

LONHALA and   are registered trademarks of Sunovion Pharmaceuticals Inc. MAGNAIR is a registered trademark of PARI Pharma GmbH, used under license.

eFlow and eLete are registered trademarks of PARI Pharma GmbH.

This site contains information intended for U.S. formulary decision-makers only.

© 2019 Sunovion Pharmaceuticals Inc. All rights reserved. 07/18 APT172-18

  • About
  • Contact Us
  • Terms of Use
  • Privacy and Cookie Notice
  • Medical Disclaimer
  • Submit a Medical Inquiry
  • Glossary

select a disease state